Consistent with the in vitro findings, xenograft tumors derived from HNRNPM-deficient cells also exhibited elevated PSAT1 levels, although tumor growth remained largely unaffected (Fig. S6A-D). The gene discussed is PSAT1; the disease is neoplasm.